1.
Koen JL, McLendon RE, George TM: Intradural spinal teratoma: evidence for a dysembryogenic origin - report of four cases. J Neurosurg 1998;89:844-851.
2.
Tibbs PA, James HE, Rorke LB, Schut L, Bruce DA: Midline hamartomas masquerading as meningomyeloceles or teratomas in the newborn infant. J Pediatr 1976;89:928-933.
3.
Spencer R: Parasitic conjoined twins: external, internal (fetuses in fetu and teratomas), and detached (acardiacs). Clin Anat 2001;14:428-444.
4.
Catala M: Embryogenesis: why do we need a new explanation for the emergence of spina bifida with lipoma? Childs Nerv Syst 1997;13:336-340.
5.
Drut R, García C, Drut RM: Poorly organized parasitic conjoined twins: report of four cases. Pediatr Pathol 1992;12:691-700.
6.
Krishna A, Lal P: Accessory limbs associated with spina bifida: a second look. Pediatr Surg Int 1999;15:248-250.
7.
Gardner WJ: Hypothesis: overdistention of the neural tube may cause anomalies of non-neural organs. Teratology 1980;22:229-238.
8.
Egar MW: Accessory limb production by nerve-induced cell proliferation. Anat Rec 1988;221:550-564.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.